25 XP   0   0   10

Cell Source Inc
Buy, Hold or Sell?

Let's analyse Cell Source Inc together

PenkeI guess you are interested in Cell Source Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cell Source Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Cell Source Inc

I send you an email if I find something interesting about Cell Source Inc.

Quick analysis of Cell Source Inc (30 sec.)










What can you expect buying and holding a share of Cell Source Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
$-0.33
Expected worth in 1 year
$-0.33
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
0.0%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0 - $0.0003
How sure are you?
50%

1. Valuation of Cell Source Inc (5 min.)




Live pricePrice per Share (EOD)

$0.00

Intrinsic Value Per Share

$-0.91 - $-0.72

Total Value Per Share

$-1.24 - $-1.05

2. Growth of Cell Source Inc (5 min.)




Is Cell Source Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$12.6m-$12.6m0.000.0%

How much money is Cell Source Inc making?

Current yearPrevious yearGrowGrow %
Making money-$5.1m-$5.1m0.000.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Cell Source Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#955 / 1010

Most Revenue
#984 / 1010

Most Profit
#437 / 1010

Most Efficient
#417 / 1010

What can you expect buying and holding a share of Cell Source Inc? (5 min.)

Welcome investor! Cell Source Inc's management wants to use your money to grow the business. In return you get a share of Cell Source Inc.

What can you expect buying and holding a share of Cell Source Inc?

First you should know what it really means to hold a share of Cell Source Inc. And how you can make/lose money.

Speculation

The Price per Share of Cell Source Inc is $0.0002. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cell Source Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cell Source Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.33. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cell Source Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.13-67,033.2%-0.13-67,033.2%-0.16-82,047.4%-0.15-74,181.1%-0.11-54,499.7%
Usd Book Value Change Per Share0.000.0%0.000.0%-0.07-36,420.7%-0.04-20,952.8%-0.03-16,402.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%8,404.034,202,014,725.2%4,826.092,413,047,200.5%
Usd Total Gains Per Share0.000.0%0.000.0%-0.07-36,420.7%8,403.994,201,993,772.4%4,826.062,413,030,797.8%
Usd Price Per Share0.46-0.46-0.85-1.14-0.70-
Price to Earnings Ratio-3.43--3.43--5.18--7.72--6.49-
Price-to-Total Gains Ratio-11.67--9.49--10.45-
Price to Book Ratio-1.40--1.40--2.59--5.22--3.68-
Price-to-Total Gains Ratio-11.67--9.49--10.45-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0002
Number of shares5000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.008,404.03
Usd Book Value Change Per Share0.00-0.04
Usd Total Gains Per Share0.008,403.99
Gains per Quarter (5000000 shares)0.0042,019,937,723.54
Gains per Year (5000000 shares)0.00168,079,750,894.15
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
100-10168080589007-838113168079750884
200-10336161178015-1676227336159501778
300-10504241767022-2514340504239252672
400-10672322356030-3352453672319003566
500-10840402945037-4190567840398754460
600-101008483534045-50286801008478505354
700-101176564123052-58667931176558256248
800-101344644712060-67049071344638007142
900-101512725301067-75430201512717758036
1000-101680805890075-83811331680797508930

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.012.00.00.0%
Book Value Change Per Share0.00.01.00.0%0.02.01.00.0%0.04.01.00.0%1.07.02.010.0%2.08.02.016.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%2.00.03.040.0%3.00.07.030.0%3.00.09.025.0%
Total Gains per Share0.00.01.00.0%0.02.01.00.0%2.02.01.040.0%4.05.01.040.0%5.06.01.041.7%

Fundamentals of Cell Source Inc

About Cell Source Inc

Cell Source, Inc., a biotechnology company, develops cell therapy treatments based on the management of immune tolerance. The company's lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. Its Veto Cell technology is used in various applications, including treatment of lymphoma, leukemia, and multiple myeloma through facilitation of the stem cell transplantation acceptance, as well as treatment of end stage kidney disease and other non-malignant organ diseases, and various cancers and non-malignant diseases. Cell Source, Inc. was incorporated in 2012 and is headquartered in New York, New York.

Fundamental data was last updated by Penke on 2024-04-20 21:48:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Cell Source Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cell Source Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cell Source Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cell Source Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.2%+207.2%
TTM--216.8%+216.8%
YOY--282.3%+282.3%
5Y--436.8%+436.8%
10Y--597.3%+597.3%
1.1.2. Return on Assets

Shows how efficient Cell Source Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cell Source Inc to the Biotechnology industry mean.
  • -1,260.9% Return on Assets means that Cell Source Inc generated $-12.61 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cell Source Inc:

  • The MRQ is -1,260.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1,260.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1,260.9%TTM-1,260.9%0.0%
TTM-1,260.9%YOY-1,260.9%0.0%
TTM-1,260.9%5Y-2,016.5%+755.6%
5Y-2,016.5%10Y-1,567.7%-448.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,260.9%-13.3%-1,247.6%
TTM-1,260.9%-12.8%-1,248.1%
YOY-1,260.9%-11.6%-1,249.3%
5Y-2,016.5%-13.8%-2,002.7%
10Y-1,567.7%-15.6%-1,552.1%
1.1.3. Return on Equity

Shows how efficient Cell Source Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cell Source Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Cell Source Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cell Source Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM--16.1%+16.1%
YOY--14.9%+14.9%
5Y--19.3%+19.3%
10Y--20.1%+20.1%

1.2. Operating Efficiency of Cell Source Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cell Source Inc is operating .

  • Measures how much profit Cell Source Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cell Source Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cell Source Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM--238.5%+238.5%
YOY--288.4%+288.4%
5Y--486.2%+486.2%
10Y--628.4%+628.4%
1.2.2. Operating Ratio

Measures how efficient Cell Source Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cell Source Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.235-3.235
TTM-3.310-3.310
YOY-3.838-3.838
5Y-5.679-5.679
10Y-7.823-7.823

1.3. Liquidity of Cell Source Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cell Source Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.03 means the company has $0.03 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cell Source Inc:

  • The MRQ is 0.031. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.031. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.031TTM0.0310.000
TTM0.031YOY0.0310.000
TTM0.0315Y0.034-0.002
5Y0.03410Y0.050-0.016
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0313.863-3.832
TTM0.0314.169-4.138
YOY0.0315.337-5.306
5Y0.0346.122-6.088
10Y0.0506.434-6.384
1.3.2. Quick Ratio

Measures if Cell Source Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cell Source Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.02 means the company can pay off $0.02 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cell Source Inc:

  • The MRQ is 0.017. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.017. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.017TTM0.0170.000
TTM0.017YOY-+0.017
TTM0.0175Y0.012+0.005
5Y0.01210Y0.014-0.002
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0173.504-3.487
TTM0.0173.991-3.974
YOY-5.371-5.371
5Y0.0126.088-6.076
10Y0.0146.395-6.381

1.4. Solvency of Cell Source Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cell Source Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cell Source Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 31.83 means that Cell Source Inc assets are financed with 3,182.6% credit (debt) and the remaining percentage (100% - 3,182.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cell Source Inc:

  • The MRQ is 31.826. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 31.826. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ31.826TTM31.8260.000
TTM31.826YOY31.8260.000
TTM31.8265Y33.113-1.286
5Y33.11310Y26.367+6.745
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ31.8260.339+31.487
TTM31.8260.337+31.489
YOY31.8260.271+31.555
5Y33.1130.368+32.745
10Y26.3670.388+25.979
1.4.2. Debt to Equity Ratio

Measures if Cell Source Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cell Source Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cell Source Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.392-0.392
TTM-0.403-0.403
YOY-0.335-0.335
5Y-0.427-0.427
10Y-0.461-0.461

2. Market Valuation of Cell Source Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cell Source Inc generates.

  • Above 15 is considered overpriced but always compare Cell Source Inc to the Biotechnology industry mean.
  • A PE ratio of -3.43 means the investor is paying $-3.43 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cell Source Inc:

  • The EOD is -0.001. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.431. Based on the earnings, the company is expensive. -2
  • The TTM is -3.431. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.001MRQ-3.431+3.430
MRQ-3.431TTM-3.4310.000
TTM-3.431YOY-5.180+1.749
TTM-3.4315Y-7.715+4.284
5Y-7.71510Y-6.486-1.230
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.001-2.300+2.299
MRQ-3.431-2.656-0.775
TTM-3.431-2.718-0.713
YOY-5.180-4.145-1.035
5Y-7.715-6.258-1.457
10Y-6.486-6.315-0.171
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cell Source Inc:

  • The EOD is -0.002. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.649. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.649. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.002MRQ-5.649+5.647
MRQ-5.649TTM-5.6490.000
TTM-5.649YOY-10.439+4.790
TTM-5.6495Y-14.975+9.326
5Y-14.97510Y-9.782-5.193
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.002-2.974+2.972
MRQ-5.649-3.306-2.343
TTM-5.649-3.508-2.141
YOY-10.439-5.613-4.826
5Y-14.975-8.378-6.597
10Y-9.782-8.873-0.909
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cell Source Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -1.40 means the investor is paying $-1.40 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cell Source Inc:

  • The EOD is -0.001. Based on the equity, the company is expensive. -2
  • The MRQ is -1.403. Based on the equity, the company is expensive. -2
  • The TTM is -1.403. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.001MRQ-1.403+1.403
MRQ-1.403TTM-1.4030.000
TTM-1.403YOY-2.593+1.190
TTM-1.4035Y-5.221+3.818
5Y-5.22110Y-3.677-1.544
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0011.914-1.915
MRQ-1.4032.116-3.519
TTM-1.4032.097-3.500
YOY-2.5932.881-5.474
5Y-5.2213.550-8.771
10Y-3.6773.936-7.613
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Cell Source Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0%-0.0730%-0.0420%-0.0330%
Book Value Per Share---0.328-0.3280%-0.3280%-0.253-23%-0.191-42%
Current Ratio--0.0310.0310%0.0310%0.034-6%0.050-37%
Debt To Asset Ratio--31.82631.8260%31.8260%33.113-4%26.367+21%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share----0%-0%8404.029-100%4826.094-100%
Eps---0.134-0.1340%-0.164+22%-0.148+11%-0.109-19%
Free Cash Flow Per Share---0.081-0.0810%-0.0810%-0.078-4%-0.068-16%
Free Cash Flow To Equity Per Share--0.0030.0030%0.0030%0.002+94%0.003+24%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.721--------
Intrinsic Value_10Y_min---0.913--------
Intrinsic Value_1Y_max---0.069--------
Intrinsic Value_1Y_min---0.086--------
Intrinsic Value_3Y_max---0.210--------
Intrinsic Value_3Y_min---0.266--------
Intrinsic Value_5Y_max---0.354--------
Intrinsic Value_5Y_min---0.450--------
Market Cap7709.240-229900%17731252.00017731252.0000%32764270.000-46%43873284.840-60%26832009.820-34%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio-0.001+100%-1.403-1.4030%-2.593+85%-5.221+272%-3.677+162%
Pe Ratio-0.001+100%-3.431-3.4310%-5.180+51%-7.715+125%-6.486+89%
Price Per Share0.000-229900%0.4600.4600%0.850-46%1.138-60%0.696-34%
Price To Free Cash Flow Ratio-0.002+100%-5.649-5.6490%-10.439+85%-14.975+165%-9.782+73%
Quick Ratio--0.0170.0170%-+100%0.012+42%0.014+22%
Return On Assets---12.609-12.6090%-12.6090%-20.165+60%-15.677+24%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share----0%-0.0730%8403.988-100%4826.062-100%
Usd Book Value---12633895.000-12633895.0000%-12633895.0000%-9756649.600-23%-7368292.200-42%
Usd Book Value Change Per Share----0%-0.0730%-0.0420%-0.0330%
Usd Book Value Per Share---0.328-0.3280%-0.3280%-0.253-23%-0.191-42%
Usd Dividend Per Share----0%-0%8404.029-100%4826.094-100%
Usd Eps---0.134-0.1340%-0.164+22%-0.148+11%-0.109-19%
Usd Free Cash Flow---3138686.000-3138686.0000%-3138686.0000%-3003579.400-4%-2621043.900-16%
Usd Free Cash Flow Per Share---0.081-0.0810%-0.0810%-0.078-4%-0.068-16%
Usd Free Cash Flow To Equity Per Share--0.0030.0030%0.0030%0.002+94%0.003+24%
Usd Market Cap7709.240-229900%17731252.00017731252.0000%32764270.000-46%43873284.840-60%26832009.820-34%
Usd Price Per Share0.000-229900%0.4600.4600%0.850-46%1.138-60%0.696-34%
Usd Profit---5167748.000-5167748.0000%-5167748.0000%-5489929.400+6%-4114403.300-20%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share----0%-0.0730%8403.988-100%4826.062-100%
 EOD+1 -6MRQTTM+0 -0YOY+4 -65Y+9 -1710Y+5 -21

3.2. Fundamental Score

Let's check the fundamental score of Cell Source Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.001
Price to Book Ratio (EOD)Between0-1-0.001
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.017
Current Ratio (MRQ)Greater than10.031
Debt to Asset Ratio (MRQ)Less than131.826
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-12.609
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Cell Source Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.434
Ma 20Greater thanMa 500.342
Ma 50Greater thanMa 1000.393
Ma 100Greater thanMa 2000.416
OpenGreater thanClose0.000
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets410
Total Liabilities13,044
Total Stockholder Equity-12,634
 As reported
Total Liabilities 13,044
Total Stockholder Equity+ -12,634
Total Assets = 410

Assets

Total Assets410
Total Current Assets410
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 223
Other Current Assets 23
Total Current Assets  (as reported)410
Total Current Assets  (calculated)246
+/- 164
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities13,044
Long-term Liabilities0
Total Stockholder Equity-12,634
Total Current Liabilities
Short-term Debt 7,904
Accounts payable 680
Other Current Liabilities 4,459
Total Current Liabilities  (as reported)13,044
Total Current Liabilities  (calculated)13,044
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock36
Retained Earnings -36,346
Other Stockholders Equity 23,674
Total Stockholder Equity (as reported)-12,634
Total Stockholder Equity (calculated)-12,636
+/- 2
Other
Cash and Short Term Investments 223
Common Stock Shares Outstanding 34,836
Liabilities and Stockholders Equity 410
Net Debt 7,682
Net Working Capital -12,634
Short Long Term Debt Total 7,904



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
> Total Assets 
22
19
123
368
211
532
532
115
452
314
410
410
4104103144521155325322113681231922
   > Total Current Assets 
22
19
121
338
211
532
532
115
452
314
410
410
4104103144521155325322113381211922
       Cash And Cash Equivalents 
22
19
19
7
4
371
371
28
245
93
223
223
223223932452837137147191922
       Other Current Assets 
0
63
26
135
70
36
36
30
30
17
23
23
232317303036367013526630
   > Long-term Assets 
0
0
2
30
0
0
0
0
4
0
0
0
0004000030200
       Property Plant Equipment 
0
0
2
1
0
0
0
0
0
0
0
0
000000001200
       Long-term Assets Other 
0
0
0
28
0
0
0
0
4
0
0
0
0004000028000
> Total Liabilities 
5
7
3,907
6,126
6,454
5,089
5,089
5,857
8,400
10,140
13,044
13,044
13,04413,04410,1408,4005,8575,0895,0896,4546,1263,90775
   > Total Current Liabilities 
5
7
3,907
6,050
6,454
5,089
5,089
5,712
8,400
10,140
13,044
13,044
13,04413,04410,1408,4005,7125,0895,0896,4546,0503,90775
       Short-term Debt 
258
231
100
1,194
3,088
2,321
2,321
2,453
4,806
6,469
0
7,904
7,90406,4694,8062,4532,3212,3213,0881,194100231258
       Short Long Term Debt 
258
231
100
180
3,088
2,321
2,673
2,453
4,806
6,469
7,904
0
07,9046,4694,8062,4532,6732,3213,088180100231258
       Accounts payable 
0
558
0
450
219
202
202
135
193
223
680
680
68068022319313520220221945005580
       Other Current Liabilities 
5
7
3,807
-449,995,595
1,175
837
628
352
-99,996,599
28
240
4,459
4,45924028-99,996,5993526288371,175-449,995,5953,80775
   > Long-term Liabilities 
0
0
100
76
3,307
0
2,523
145
4,999
3,212,503,000
0
0
003,212,503,0004,9991452,52303,3077610000
       Other Liabilities 
0
0
0
4
0
0
0
0
0
0
0
0
000000004000
       Deferred Long Term Liability 
0
0
0
28
0
0
0
0
0
0
0
0
0000000028000
> Total Stockholder Equity
17
11
-3,784
-5,758
-6,243
-4,557
-4,557
-5,742
-7,947
-9,826
-12,634
-12,634
-12,634-12,634-9,826-7,947-5,742-4,557-4,557-6,243-5,758-3,7841117
   Common Stock
6
6
24
24
25
25
25
27
33
34
36
36
3636343327252525242466
   Retained Earnings -36,346-36,346-31,178-25,706-21,146-14,553-14,553-11,470-10,503-7,998-31-5
   Capital Surplus 
0
0
0
0
0
0
0
0
17,725
0
0
0
00017,72500000000
   Treasury Stock000000000000
   Other Stockholders Equity 
17
36
4,191
4,720
5,203
0
9,970
15,376
17,725
21,316
0
23,674
23,674021,31617,72515,3769,97005,2034,7204,1913617



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-4,175
Operating Income-4,175-4,175
 
Operating Expense (+$)
Research Development1,996
Selling General Administrative2,179
Selling And Marketing Expenses0
Operating Expense4,1754,175
 
Net Interest Income (+$)
Interest Income0
Interest Expense-992
Other Finance Cost-269
Net Interest Income-1,261
 
Pretax Income (+$)
Operating Income-4,175
Net Interest Income-1,261
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-5,168992,410,825
EBIT - interestExpense = -5,168
-992,419,180
-4,175
Interest Expense992
Earnings Before Interest and Taxes (EBIT)-4,175-4,175
Earnings Before Interest and Taxes (EBITDA)-4,175
 
After tax Income (+$)
Income Before Tax-5,168
Tax Provision-0
Net Income From Continuing Ops-5,609-5,168
Net Income-5,168
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses4,175
Total Other Income/Expenses Net-992,415,0001,261
 

Technical Analysis of Cell Source Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cell Source Inc. The general trend of Cell Source Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cell Source Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cell Source Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.0003 < 0.0003 < 0.0003.

The bearish price targets are: .

Tweet this
Cell Source Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cell Source Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cell Source Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cell Source Inc. The current macd is -0.11506238.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cell Source Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cell Source Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cell Source Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Cell Source Inc Daily Moving Average Convergence/Divergence (MACD) ChartCell Source Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cell Source Inc. The current adx is 55.98.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Cell Source Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Cell Source Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cell Source Inc. The current sar is 0.38730519.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Cell Source Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cell Source Inc. The current rsi is 26.43. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Cell Source Inc Daily Relative Strength Index (RSI) ChartCell Source Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cell Source Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cell Source Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Cell Source Inc Daily Stochastic Oscillator ChartCell Source Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cell Source Inc. The current cci is -133.33333333.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Cell Source Inc Daily Commodity Channel Index (CCI) ChartCell Source Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cell Source Inc. The current cmo is -64.20254646.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Cell Source Inc Daily Chande Momentum Oscillator (CMO) ChartCell Source Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cell Source Inc. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Cell Source Inc Daily Williams %R ChartCell Source Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cell Source Inc.

Cell Source Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cell Source Inc. The current atr is 0.0777291.

Cell Source Inc Daily Average True Range (ATR) ChartCell Source Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cell Source Inc. The current obv is 53,122.

Cell Source Inc Daily On-Balance Volume (OBV) ChartCell Source Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cell Source Inc. The current mfi is 9.16127301.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Cell Source Inc Daily Money Flow Index (MFI) ChartCell Source Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cell Source Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Cell Source Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cell Source Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.434
Ma 20Greater thanMa 500.342
Ma 50Greater thanMa 1000.393
Ma 100Greater thanMa 2000.416
OpenGreater thanClose0.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Cell Source Inc with someone you think should read this too:
  • Are you bullish or bearish on Cell Source Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cell Source Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cell Source Inc

I send you an email if I find something interesting about Cell Source Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Cell Source Inc.

Receive notifications about Cell Source Inc in your mailbox!